Back
CASI Pharmaceuticals Quote, Financials, Valuation and Earnings
Sell
46
CASI
CASI Pharmaceuticals
Last Price:
3.24
Seasonality Move:
-12.73%
7 Day Trial
ALL ACCESS PASS
$
7
CASI Pharmaceuticals Price Quote
$3.24
-0.03 (-0.92%)
(Updated: May 16, 2024 at 6:55 PM ET)
CASI Pharmaceuticals Key Stats
Sell
46
CASI Pharmaceuticals (CASI)
is a Sell
Day range:
$3.26 - $3.54
52-week range:
$1.85 - $8.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.29
P/B ratio:
1.81%
Volume:
60.2K
Avg. volume:
25.7K
1-year change:
29.29%
Market cap:
$43.8M
Revenue:
$33.9M
EPS:
$-2.03
How Much Does CASI Pharmaceuticals Make?
-
How Much Are CASI Pharmaceuticals's Sales Annually?
CASI Revenues are $33.9M -
How Much Profit Does CASI Pharmaceuticals's Make A Year?
CASI net income is -$26.9M
Is CASI Pharmaceuticals Growing As A Company?
-
What Is CASI Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.55% -
What Is CASI Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
CASI Pharmaceuticals Stock Price Performance
-
Did CASI Pharmaceuticals Stock Go Up Last Month?
CASI Pharmaceuticals share price went up by 30.8% last month -
Did CASI's Share Price Rise Over The Last Year?
CASI share price rose by 29.29% over the past 1 year
What Is CASI Pharmaceuticals 52-Week High & Low?
-
What Is CASI Pharmaceuticals’s 52-Week High Share Price?
CASI Pharmaceuticals has traded as high as $8.48 over the past 52 weeks -
What Is CASI Pharmaceuticals’s 52-Week Low Share Price?
CASI Pharmaceuticals has traded as low as $1.85 over the past 52 weeks
CASI Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy CASI Pharmaceuticals?
-
How Much Debt Does CASI Pharmaceuticals Have?
Total long term debt quarterly is $18.9M -
How Much Cash Does CASI Pharmaceuticals Have?
Cash and short term investments quarterly total is $30.8M -
What Is CASI Pharmaceuticals’s Book Value Per Share?
Book value per share is 1.81
Is CASI Pharmaceuticals Cash Flow Positive?
Data Unavailable
CASI Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
CASI return on invested capital is -48.71% -
What Is CASI Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -32.69% -
What Is CASI Return On Equity?
ROE is a measure of profitability and is -52.29%
CASI Pharmaceuticals Earnings Date & Stock Price
-
What Is CASI Pharmaceuticals's Stock Price Today?
A single share of CASI can be purchased today for 3.27 -
What Is CASI Pharmaceuticals’s Stock Symbol?
CASI Pharmaceuticals trades on the nasdaq under the ticker symbol: CASI -
When Is CASI Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for CASI Pharmaceuticals is scheduled on May 20, 2024 -
When Is CASI's next ex-dividend date?
CASI Pharmaceuticals's next ex-dividend date is May 1, 2020 -
How To Buy CASI Pharmaceuticals Stock?
You can buy CASI Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CASI Pharmaceuticals Competitors
-
Who Are CASI Pharmaceuticals's Competitors?
Below is a list of companies who compete with CASI Pharmaceuticals or are related in some way:
CASI Pharmaceuticals Dividend Yield
Data Unavailable
CASI Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -1320% |
| Revenue: | -54.95% | -71.59% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 12.00 |
| Upside from Last Price: | 266.97% |